UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment Review article
2022
Authors:  Ge, Pu;  Wan, Ning;  Han, Xiao;  Wang, Xinpei;  Zhang, Jinzi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.4/5.0 | Submit date:2023/01/30
Aflibercept  Cost-effectiveness Analysis  Metastatic Colorectal Cancer  Pharmacoeconomics  Rapid Health Technology Assessment  Targeted Drugs  
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines? Journal article
Huang, Cong, Ung, Carolina Oi Lam, Wushouer, Haishaerjiang, Bai, Lin, Huang, Tao, Li, Xinyi, Guan, Xiaodong, Shi, Luwen. Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?[J]. Health Research Policy and Systems, 2022, 20(1), 3.
Authors:  Huang, Cong;  Ung, Carolina Oi Lam;  Wushouer, Haishaerjiang;  Bai, Lin;  Huang, Tao; et al.
Favorite | TC[WOS]:10 TC[Scopus]:12  IF:3.6/4.3 | Submit date:2022/05/13
Health Technology Assessment  Pricing Negotiation  Targeted Anticancer Medicines